Albertsons Companies (ACI) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
9 Jul, 2026Executive summary
Q4 identical sales rose 2.3% year-over-year, with digital sales up 24% and loyalty members increasing 15% to over 45M.
Adjusted EBITDA for Q4 was $855M and adjusted EPS was $0.46, reflecting strong digital and customer engagement strategies.
Leadership transition underway with Susan Morris succeeding Vivek Sankaran as CEO, emphasizing continuity in strategic priorities.
Focus areas include digital platform expansion, loyalty program growth, pharmacy integration, and productivity initiatives.
Significant investments planned in technology, automation, and the Albertsons Media Collective to drive future growth.
Financial highlights
Q4 net sales were $18.8B, up from $18.3B, driven by pharmacy and digital sales growth.
Q4 gross margin was 27.4%, down from 28.0% year-over-year, mainly due to pharmacy and digital mix.
Adjusted EBITDA for Q4 was $855M (vs. $916M prior year); adjusted EPS was $0.46 (vs. $0.54 prior year).
Net debt leverage at quarter-end was 1.9x; capital expenditures were $485M, mainly for store modernization and digital platforms.
Returned $87M to shareholders via dividends and repurchased $83M in stock during Q4.
Outlook and guidance
Fiscal 2025 guidance: ID sales growth of 1.5%-2.5% with inflation of 1.5%-2%.
Adjusted EBITDA expected at $3.8B-$3.9B, including $65M from the 53rd week; adjusted EPS of $2.03-$2.16.
Capital expenditures projected at $1.7B-$1.9B; effective tax rate of 23.5%-24.5%.
Long-term algorithm targets 2%+ ID sales and higher EBITDA growth in 2026 and beyond.
Latest events from Albertsons Companies
- Identical sales and digital growth lifted revenue, but margins narrowed and EBITDA declined.ACI
Q1 20268 Jul 2026 - Proxy covers director elections, governance reforms, and robust ESG and compensation practices.ACI
Proxy filing22 Jun 2026 - Key votes include director elections, auditor ratification, and governance amendments.ACI
Proxy filing22 Jun 2026 - Proxy covers director elections, compensation, governance reforms, and ESG priorities.ACI
Proxy filing8 Jun 2026 - Q4 net loss from opioid settlement; digital sales up 16% and dividend raised 13%.ACI
Q4 202614 Apr 2026 - Q3 delivered solid sales and digital growth, but faces post-merger litigation and margin pressure.ACI
Q3 202510 Jan 2026 - Q3 2025 saw 2.4% identical sales growth, strong digital gains, and major capital actions.ACI
Q3 20267 Jan 2026 - Q2 2025 saw 2.0% revenue growth, higher net income, and a $750M share buyback announcement.ACI
Q2 20267 Jan 2026 - Board recommends against all shareholder proposals; focus remains on digital growth and ESG impact.ACI
Proxy Filing1 Dec 2025